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THE IMPLICATIONS OF
OUTCOME PREDICTORS
WHEN TRANSITIONING FROM
ARTERIALTO DOUBLE-
SWITCH SURGERY
To the Editor:
I read with great interest the fate of
the systemic ventricle after double-
switch surgery among those who had
left ventricle (LV) training.1 The
authors concluded that LV training
with pulmonary artery (PA) banding
resulted in a worse outcome after the
double-switch procedure. I would like
to add a few potential explanations
for their findings. One of the impor
tant aspects of the decline in function
can be related to the coronary circula-
tion and its aberrant network in
patients with corrected transposition
of the great arteries.2 This has been
Letters to the EditorHYPOXIA-INDUCIBLE
FACTOR-1a IN STEM CELL
PRECONDITIONING:
MECHANISTIC ROLE OF
HYPOXIA-RELATED MICRO-
RNAS
To the Editor:
Since its inception more than 2 de-
cades ago, ischemic preconditioning
(IP) is considered as the most powerful
cytoprotective stimulus and is being
devised as a potent strategy to promote
stem cell survival post-engraftment in
the infarcted heart.1 The elegant study
from Hu and colleagues2 is a step for-
ward toward the use of low oxygen cul-
ture conditions to trigger activation of
survival signaling pathways in the cells
before their engraftment in vivo. The
authors showed significantly improved
survival of the hypoxia-treated (0.5%
oxygen for 24 hours) mesenchymal
stem cells after engraftment in the in-
farcted heart. Unlikemany of the previ-
ous studies, an important aspect of the
study protocol was cell engraftment
during the acute phase of myocardial
infarction to assess the effectiveness
of a preconditioning approach. Acute
phase engraftment exposed the en-
grafted cells to the harsh, cytokine-
rich microenvironment of the infarcted
myocardium, which was aggravated
even more because of the infiltration
of inflammatory and progenitor cells
as a part of the intrinsic repair
process. The authors attributed the
effectiveness of the hypoxic precondi-
tioning approach to up-regulation of
hypoxia inducible factor (HIF)-1a, a
heterodimeric master switch of a
hypoxia-responsive array of genesThe Journathat enable the cells to acclimatize
and survive in low oxygen conditions.
Although a low-level presence of
HIF-1a has been reported in the cyto-
plasmic compartment of cells grown
under normoxia, hypoxia stabilizes
HIF-1a against degradation and pro-
motes its translocation to the nucleus,
where it forms functional complexes
for gain of functions. As a part of our
continuing endeavor to precondition
donor cells for their better survival in
the infarcted heart and that too with
clinical relevance,3 we share our expe-
rience of extrapolating the classic IP
strategy of exposing the cells to multi-
ple sublethal ischemia/reoxygenation
cycles of short duration to promote
mesenchymal stem cell survival
(unpublished data). This approach rep-
resents an extension of the one-time,
long-term exposure to sublethal
hypoxia approach suggested by Hu
and colleagues.2 Our results showed
significant up-regulation of HIF-1a in
an Akt-dependent manner in the cells
preconditioned by 2 cycles of ische-
mia-reperfusion of 30 minutes each.
These molecular events successfully
attenuated donor cell attrition on subse-
quent exposure to lethal ischemic
insult. The participation of hypoxia-
associated micro RNAs (miR), miR-
107 and miR-210,4 downstream of
HIF-1a in translation of cytoprotective
effects of IP was another important
observation in our study. HIF-1a–
specific RNA interference abrogated
both miR-107 and miR-210 in the
preconditioned cells transfected with
HIF-1a–specific siRNA with a con-
comitant increase in preponderance of
apoptotic cells. Our in vivo experimen-
tal results in a rodent model of acute
myocardial infarction showed that
transplanted preconditioned cells sur-
vived significantly better compared
with their nonpreconditioned counter-
parts. Moreover, transplantation of
preconditioned cells promoted miR-
107 and -210 expression in the in-
farcted heart at the site of the cell graft.
These novel findings necessitate more
in-depth studies to elucidate whetherl of Thoracic and Cardiovascular Surgthe effect of IP can be duplicated by
manipulation of the cells for hypoxia-
related miRNAs to promote donor
cell survival.
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